These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 17412584)

  • 1. Synthesis and biological activity of 2-alkylbenzimidazoles bearing a N-phenylpyrrole moiety as novel angiotensin II AT1 receptor antagonists.
    Xu JY; Zeng Y; Ran Q; Wei Z; Bi Y; He QH; Wang QJ; Hu S; Zhang J; Tang MY; Hua WY; Wu XM
    Bioorg Med Chem Lett; 2007 May; 17(10):2921-6. PubMed ID: 17412584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antihypertensive activity of pyrimidin-4(3H)-one derivatives as losartan analogue for new angiotensin II receptor type 1 (AT1) antagonists.
    Kim TW; Yoo BW; Lee JK; Kim JH; Lee KT; Chi YH; Lee JY
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1649-54. PubMed ID: 22264484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and biological evaluation of 6-substituted aminocarbonyl benzimidazole derivatives as nonpeptidic angiotensin II AT1 receptor antagonists.
    Wang JL; Zhang J; Zhou ZM; Li ZH; Xue WZ; Xu D; Hao LP; Han XF; Fei F; Liu T; Liang AH
    Eur J Med Chem; 2012 Mar; 49():183-90. PubMed ID: 22309912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and biological activity of 6-substituted carbamoyl benzimidazoles as new nonpeptidic angiotensin II AT₁ receptor antagonists.
    Zhang J; Wang JL; Zhou ZM; Li ZH; Xue WZ; Xu D; Hao LP; Han XF; Fei F; Liu T; Liang AH
    Bioorg Med Chem; 2012 Jul; 20(14):4208-16. PubMed ID: 22727371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of new tetrazolyl- and carboxy-biphenylylmethyl-quinazolin-4-one derivatives as angiotensin II AT1 receptor antagonists.
    Ismail MA; Barker S; Abou el-Ella DA; Abouzid KA; Toubar RA; Todd MH
    J Med Chem; 2006 Mar; 49(5):1526-35. PubMed ID: 16509571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, structural studies, biological evaluation, and computational simulations of novel potent AT(1) angiotensin II receptor antagonists based on the 4-phenylquinoline structure.
    Cappelli A; Pericot Mohr Gl Gl; Gallelli A; Rizzo M; Anzini M; Vomero S; Mennuni L; Ferrari F; Makovec F; Menziani MC; De Benedetti PG; Giorgi G
    J Med Chem; 2004 May; 47(10):2574-86. PubMed ID: 15115399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computer--based drug design, synthesis and biological evaluation of new pyrimidinone derivatives linked to arylpiperazine and 2'-carbethoxy-biphenylylmethyl moeities as alpha1-adrenoceptor antagonists and angiotensin II AT1 receptor antagonists.
    Ismail MA; Abou El Ella DA; Abouzid KA; Al-Ansary GH
    Pharmazie; 2010 Nov; 65(11):794-800. PubMed ID: 21155384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 1. Construction of the basic framework.
    Abe Y; Kayakiri H; Satoh S; Inoue T; Sawada Y; Imai K; Inamura N; Asano M; Hatori C; Katayama A; Oku T; Tanaka H
    J Med Chem; 1998 Feb; 41(4):564-78. PubMed ID: 9484506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonpeptidic angiotensin II AT₁ receptor antagonists derived from 6-substituted aminocarbonyl and acylamino benzimidazoles.
    Zhang J; Wang JL; Yu WF; Zhou ZM; Tao WC; Wang YC; Xue WZ; Xu D; Hao LP; Han XF; Fei F; Liu T; Liang AH
    Eur J Med Chem; 2013 Nov; 69():44-54. PubMed ID: 24007859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of novel potent angiotensin II receptor antagonists with anti-hypertension effect.
    Nie YY; Da YJ; Zheng H; Yang XX; Jia L; Wen CH; Liang LS; Tian J; Chen ZL
    Bioorg Med Chem; 2012 Apr; 20(8):2747-61. PubMed ID: 22410249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The discovery of new potent non-peptide Angiotensin II AT1 receptor blockers: a concise synthesis, molecular docking studies and biological evaluation of N-substituted 5-butylimidazole derivatives.
    Agelis G; Resvani A; Durdagi S; Spyridaki K; Tůmová T; Slaninová J; Giannopoulos P; Vlahakos D; Liapakis G; Mavromoustakos T; Matsoukas J
    Eur J Med Chem; 2012 Sep; 55():358-74. PubMed ID: 22889560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, anti-hypertensive effect of a novel angiotensin II AT1 receptor antagonist and its anti-tumor activity in prostate cancer.
    Da YJ; Yuan WD; Zhu LF; Chen ZL
    Arzneimittelforschung; 2012 Dec; 62(12):637-43. PubMed ID: 23203543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of angiotensin II antagonism displayed by Ib, a novel nonpeptide angiotensin AT(1) receptor antagonist.
    Wu J; Wang Q; Guo J; Hu Z; Yin Z; Xu J; Wu X
    Eur J Pharmacol; 2008 Jul; 589(1-3):220-4. PubMed ID: 18571160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further studies on imidazo[4,5-b]pyridine AT1 angiotensin II receptor antagonists. Effects of the transformation of the 4-phenylquinoline backbone into 4-phenylisoquinolinone or 1-phenylindene scaffolds.
    Cappelli A; Pericot Mohr Gl; Giuliani G; Galeazzi S; Anzini M; Mennuni L; Ferrari F; Makovec F; Kleinrath EM; Langer T; Valoti M; Giorgi G; Vomero S
    J Med Chem; 2006 Nov; 49(22):6451-64. PubMed ID: 17064065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NO-sartans: a new class of pharmacodynamic hybrids as cardiovascular drugs.
    Breschi MC; Calderone V; Digiacomo M; Martelli A; Martinotti E; Minutolo F; Rapposelli S; Balsamo A
    J Med Chem; 2004 Nov; 47(23):5597-600. PubMed ID: 15509155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct action of an angiotensin II receptor blocker on angiotensin II-induced left atrial conduction delay in spontaneously hypertensive rats.
    Matsuyama N; Tsutsumi T; Kubota N; Nakajima T; Suzuki H; Takeyama Y
    Hypertens Res; 2009 Aug; 32(8):721-6. PubMed ID: 19590505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldosterone causes vasoconstriction in coronary arterioles of rats via angiotensin II type-1 receptor: influence of hypertension.
    Kushibiki M; Yamada M; Oikawa K; Tomita H; Osanai T; Okumura K
    Eur J Pharmacol; 2007 Oct; 572(2-3):182-8. PubMed ID: 17644087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonpeptide angiotensin II receptor antagonists: synthesis, biological activities, and structure-activity relationships of imidazole-5-carboxylic acids bearing alkyl, alkenyl, and hydroxyalkyl substituents at the 4-position and their related compounds.
    Yanagisawa H; Amemiya Y; Kanazaki T; Shimoji Y; Fujimoto K; Kitahara Y; Sada T; Mizuno M; Ikeda M; Miyamoto S; Furukawa Y; Koike H
    J Med Chem; 1996 Jan; 39(1):323-38. PubMed ID: 8568823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and evaluation of novel potent angiotensin II receptor 1 antagonists.
    Bao X; Zhu W; Yuan W; Zhu X; Yan Y; Tang H; Chen Z
    Eur J Med Chem; 2016 Nov; 123():115-127. PubMed ID: 27474928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel Sartan derivative with very low angiotensin II type 1 receptor affinity protects the kidney in type 2 diabetic rats.
    Izuhara Y; Sada T; Yanagisawa H; Koike H; Ohtomo S; Dan T; Ito S; Nangaku M; van Ypersele de Strihou C; Miyata T
    Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1767-73. PubMed ID: 18658044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.